ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Galectin-7 in Cardiac Allografts in Mice: Related to the Acute Rejection and Playng Important Roles in Accelerating Rejection Response

    Z. Luo, Z. Chen

    Institute of Organ Transplantation,Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China

    To survey whether galectin-7 is associated with acute rejection and the function of galectin-7 in acute allograft rejection.In this study, the allografts and isografts were…
  • 2013 American Transplant Congress

    Cumulative Effect of Metabolic Syndrome Components in Predicting Major Adverse Cardiovascular Events after Kidney Transplantation

    G. Prasad, M. Huang, S. Silver, A. Allawati, L. Rapi, M. Nash, J. Zaltzman

    Medicine, University of Toronto, Toronto, ON, Canada; Renal Transplant Program, St. Michael's Hospital, Toronto, ON, Canada

    Background: Metabolic syndrome (MS) refers to a clustering of factors that increases cardiovascular risk. The WHO 1999 definition of MS includes the presence of any…
  • 2013 American Transplant Congress

    Economic Impact of Pulsatile Hyothermic Perfusion in an Expanded Criteria Donor Transplant Program. Analysis of the First Year Implementation

    V. Gómez, V. Diéz, C. Galeano, A. Gomis, V. Hevia, M. Jiménez, R. Rodriguez-Patrón, F. Arias, C. Quereda, F. Burgos

    Urology, Ramón y Cajal Hospital, Madrid, Spain; Nephrology, Ramón y Cajal Hospital, Madrid, Spain; Alcalá University, Madrid, Spain

    INTRODUCTIONKidney transplant (KT) from expanded criteria donors (ECD) have a higher rate of delayed graft function (DGF) that increases postoperative costs because of prolonged hospital…
  • 2013 American Transplant Congress

    Characterization of the Immune Response after Intravenous Infusion of Mesenchymal Stem Cells

    M. Hoogduijn, M. Roemeling-van Rhijn, A. Engela, S. Korevaar, F. Mensah, M. Franquesa, R. de Bruin, M. Betjes, W. Weimar, C. Baan

    Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands; Surgery, Erasmus Medical Center, Rotterdam, Netherlands

    Experimental animal models show beneficial effects of administration of mesenchymal stem cells (MSC) on ischemia-reperfusion injury and survival of organ transplants. The immunomodulatory responses that…
  • 2013 American Transplant Congress

    Can the Risk of Cancer Transmission from Organ Donors Be Eliminated?

    R. Desai, D. Collett, C. Watson, P. Johnson, T. Evans, J. Neuberger

    Organ Donation and Transplantation, NHS Blood and Transplant, Bristol, United Kingdom; Department of Surgery, Addenbrooke's Hospital, Cambridge, United Kingdom; School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom; West Midlands Cancer Intelligence Unit, University of Birmingham, Birmingham, United Kingdom

    Donor origin cancer (DOC) in transplant recipients may be transmitted with the graft (donor-transmitted cancer [DTC]) or develop subsequently from the graft (donor-derived cancer [DDC]).…
  • 2013 American Transplant Congress

    Long-Term Outcomes of Liver Transplant Patients with HIV-1 Infection: a 14-Year Single-Center Clinical Experience

    S. Yamamoto, R. Schwarcz, O. Weiland, A. Oksanen, A. Wernersson, G. Söderdahl, A. Sönnerborg, B. Ericzon

    Transplantation Surgery, Karolinska University Hospital, Huddinge, Stockholm, Sweden; Infectious Disease, Karolinska University Hospital, Huddinge, Stockholm, Sweden; Gastroenterology and Hepatology, Karolinska University Hospital, Huddinge, Stockholm, Sweden; Clinical Pathology and Cytology, Karolinska University Hospital, Huddinge, Stockholm, Sweden

    Background: Liver transplantation (LT) for patients with Human immunodeficiency virus type-1 (HIV-1) infection has been associated with poor outcome. However, after the introduction of the…
  • 2013 American Transplant Congress

    Understanding Transplant Education Practices in Dialysis Centers: Comparing Dialysis Educator and Medicare Patient Data

    A. Waterman, J. Peipert, H. Xiao, C. Goalby, E. Herrington, S. Munigala, K. Dinkel, K. Lentine

    Washington University School of Medicine, St. Louis, MO; Center for Outcomes Research, St. Louis University, St. Louis, MO; Heartland Kidney Network, Kansas City, MO

    The Centers for Medicare and Medicaid Services’ (CMS) mandates that dialysis centers inform patients of their transplant options and report progress of this within 45…
  • 2013 American Transplant Congress

    Grading System for Micro-Vascular Invasion in Transplanted Hepatocellular Cancer, A

    N. Lubezky, H. Noboru, E. Silberman, P. Tabrizian, H. Ko, A. Harrington, J. Hernandez-Prera, M. Fiel, S. Thung, M. Schwartz, S. Roayaie

    Mount Sinai Liver Cancer Program, Mount Sinai Medical Center, New York, NY; The Lillian and Henry M. Stratton-Hans Popper Department of Pathology, Mount Sinai Medical Center, New York, NY

    Background & Aims: Microvascular invasion (mVI) has repeatedly been correlated with recurrence and survival after liver transplantation (OLT) for hepatocellular cancer (HCC). A grading system…
  • 2013 American Transplant Congress

    HLA Class I Antibody Augments FGF-23 Induced Transplant Vasculopathy and Chronic Antibody Mediated Rejection

    E. Tsai, Y. Jin, K. Wesseling-Perry, I. Salusky, R. Ettenger, E. Reed

    Pediatric Nephrology, UCLA, Los Angeles, CA; Pathology and Laboratory Medicine, UCLA, Los Angeles, CA

    Background: Fibroblast growth factor 23 (FGF-23), which binds to FGF receptor, has been associated with allograft rejection, CKD progression, and poor graft survival in pediatric…
  • 2013 American Transplant Congress

    NFAT-Dependent Cytokine and p70S6 Kinase Activity Assays as Immune Monitoring Tools for Transplant Patients on CNIs and mTOR Inhibitors

    A. Webber, R. Hirose, C. Leung, F. Vincenti

    Kidney Transplant Service, UCSF, San Francisco, CA

    Objective: To compare NFAT-regulated gene expression and p70S6k activity in kidney transplant patients maintained on full-dose tacrolimus plus MPA versus reduced-dose tacrolimus and everolimus.Methods: Peripheral…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences